Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Design and Evaluation of Modified Release Dosage Form Containing Bupropion Hydrochloride


Affiliations
1 Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana-384 001, India
2 Parul Institute of Pharmacy, Baroda-391760, India
3 Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana-384 001, India
     

   Subscribe/Renew Journal


In the present investigation an attempt was made to reduce the frequency of dose administration, to improve the patient compliance by developing Modified release matrix tablet of Bupropion Hydrochloride (BPH). Bupropion has been approved by the Food and Drug Administration (FDA) for use in smoking cessation. Eleven batches of matrix tablets of BPH were developed by using direct compression technique and coated with Opadry white. Compressed tablets were evaluated for weight variation, hardness, friability, similarity factor (f2) and in vitro dissolution using paddle (USP type II) method. Drug excipients compatibility study was also performed using differential scanning calorimetry (DSC). All the formulations were compared with the innovator. Among the eleven formulations F11 batch shows comparative dissolution profile with the innovator.


Keywords

Bupropion Hydrochloride Tablet, In-vitro Dissolution Study, DSC.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 230

PDF Views: 0




  • Design and Evaluation of Modified Release Dosage Form Containing Bupropion Hydrochloride

Abstract Views: 230  |  PDF Views: 0

Authors

Dipen Patel
Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana-384 001, India
D. M. Patel
Parul Institute of Pharmacy, Baroda-391760, India
S. T. Prajapati
Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana-384 001, India
J. B. Dave
Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana-384 001, India
C. N. Patel
Shri Sarvajanik Pharmacy College, Near Arvind Baug, Mehsana-384 001, India

Abstract


In the present investigation an attempt was made to reduce the frequency of dose administration, to improve the patient compliance by developing Modified release matrix tablet of Bupropion Hydrochloride (BPH). Bupropion has been approved by the Food and Drug Administration (FDA) for use in smoking cessation. Eleven batches of matrix tablets of BPH were developed by using direct compression technique and coated with Opadry white. Compressed tablets were evaluated for weight variation, hardness, friability, similarity factor (f2) and in vitro dissolution using paddle (USP type II) method. Drug excipients compatibility study was also performed using differential scanning calorimetry (DSC). All the formulations were compared with the innovator. Among the eleven formulations F11 batch shows comparative dissolution profile with the innovator.


Keywords


Bupropion Hydrochloride Tablet, In-vitro Dissolution Study, DSC.